HB 220

  • Kentucky House Bill
  • 2024 Regular Session
  • Introduced in House Jan 10, 2024
  • Passed House Feb 02, 2024
  • Passed Senate Mar 08, 2024
  • Signed by Governor Mar 14, 2024

AN ACT relating to step therapy protocols.

Abstract

Amend KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; make findings and establish intent of Act.

Bill Sponsors (5)

Votes


Actions


Mar 14, 2024

House

signed by Governor (Acts Ch. 4)

Mar 08, 2024

House

delivered to Governor

Senate

enrolled, signed by President of the Senate

House

enrolled, signed by Speaker of the House

House

received in House

Mar 07, 2024

House

3rd reading, passed 37-0

Mar 06, 2024

House

posted for passage in the Regular Orders of the Day for Thursday, March 07, 2024

Feb 28, 2024

House

2nd reading, to Rules

Feb 27, 2024

House

reported favorably, 1st reading, to Calendar

Feb 22, 2024

Senate

to Banking & Insurance (S)

Feb 05, 2024

Senate

to Committee on Committees (S)

Senate

received in Senate

Feb 02, 2024

House

3rd reading, passed 91-0 with Committee Substitute (1) and Committee Amendment (1-title)

Feb 01, 2024

House

posted for passage in the Regular Orders of the Day for Friday, February 02, 2024

House

2nd reading, to Rules

Jan 31, 2024

House

reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title)

Jan 25, 2024

House

reassigned to Banking & Insurance (H)

Jan 24, 2024

House

to Health Services (H)

Jan 10, 2024

House

to Committee on Committees (H)

House

introduced in House

Bill Text

Bill Text Versions Format
Acts Chapter 4 PDF
Current/Final PDF
Introduced PDF

Related Documents

Document Format
Proposed House Committee Amendment 1
Proposed House Committee Substitute 1

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.